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Long QT syndrome (LQTS) is an arrhythmogenic cardiovascular disorder resulting from mutations in cardiac ion 
channels. LQTS is characterized by prolonged ventricular repolarization and frequently manifests itself as QT interval 
prolongation on the electrocardiogram (ECG). A variety of commonly prescribed anesthetic drugs possess the 
adverse property of prolonging cardiac repolarization and may provoke serious ventricular tachyarrhythmia called 
‘torsades de pointes’ , ventricular fibrillation, and sudden death. We experienced a case of ventricular tachycardia and 
ventricular fibrillation after anesthetic induction and it came out into the open that anesthetic induction provoked 
long QT syndrome. (Korean J Anesthesiol 2010; 59: S114-S118)
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    Long QT syndrome (LQTS) is a cardiovascular disorder 
characterized by prolonged ventricular repolarization and 
prolongation of the QT interval on the electrocardiogram (ECG), 
which may occasionally cause serious arrhythmias leading 
to sudden cardiac death. Routinely, patients admitted for 
operation are required to take a variety of prescription drugs, 
some of which can provoke negative effects in patients by 
prolonging cardiac repolarization. Medications administered 
during general anesthesia are known to influence QT intervals 
[1], and such drug-induced QT prolongation may increase the 
risk of ventricular arrhythmias in patients with LQTS which can 
be fatal.
    We witnessed a case diagnosed with LQTS following 
ventricular fibrillation after the induction of general anesthesia 
in a patient, for open reduction of fracture of the zygomatic 
bone on the right side. We report our clinical experience and 
review the relevant literature. 
Case Report
    A 32-year-old, 173 cm, 79 kg male patient was admitted to the 
emergency room (ER) for the treatment of facial pain due to an 
automobile accident. On arrival, he was fully conscious with an 
Glasgow Coma Scale score of 15/15 and stable vital signs: blood 
pressure (BP) 115/76 mmHg, heart rate (HR) 58 beats/min, and 
body temperature 37
oC. Frontal skull fracture was suspected, S115 www.ekja.org
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and an X-ray skull and computed tomography (CT) were taken 
which demonstrated a fracture of the zygomatic bone on the 
right side. Under general anesthesia, an open reduction of the 
right sided zygomatic bone fracture was planned. Patient’s 
medical history, neurological and physical examinations 
were normal. Preoperative blood test findings were normal: 
Na
+ 143 mEq/L, K
+ 3.9 mEq/L, Cl
- 106 mEq/L, Ca
2+ 9.3 mg/
dl. The electrocardiogram (ECG) and chest X-ray results were 
also normal (Fig. 1). No premedication was provided, and the 
patient’s vital signs were measured immediately after entering 
the operating room (OR); BP was 120/80 mmHg, HR was 50 
beats/min, and pulse oximetry (SpO2) was 99%. Due to the 
facial injury, facemask ventilation was thought to be difficult to 
perform and hence, manual assisted ventilation, using rapid-
sequence induction, with O2 of 5 L/min was performed and, 450 
mg of thiopental and 80 mg of succinylcholine were injected 
intravenously one after another. After tracheal intubation, 
manual assisted ventilation was performed with 2.0 vol% of 
sevoflurane. 
    Immediately after tracheal intubation, BP increased from 
120/80 to 160/90 mmHg and HR rose from 50 to 120 beats/min, 
and premature ventricular complexes (PVC) were detected 
on ECG. Therapy for ventricular arrthymias was intitated 
with a 70 mg of lidocaine intravenous injection, but the 
ventricular arrhythmias changed into patterns of ventricular 
bigeminy, ventricular tachycardia (VT), and torsades de 
pointes subsequently; BP measured at that time was 60/30 
mmHg. Immediately, the administration of sevoflurane was 
discontinued and manual assisted ventilation was performed 
with 100% O2, while an external cardiac defibrillator was being 
prepared for attempting defibrillation. As an intravenous 
injection of esmolol was being prepared, ventricular fibrillation 
(VF) without measurable BP was detected. Instantly, 
cardiopulmonary resuscitation (CPR) by chest compression 
was performed. As early defibrillation was attempted using 360 
J, chest compression was resumed and 1 mg of epinephrine 
was administered intravenously. Thereafter, VF on ECG 
disappeared, and the heart rhythm returned to its normal sinus 
rhythm (NSR). Considering it difficult to proceed with the 
operation, the patient was transferred to the intensive care unit 
(ICU) as soon as the patient’s vital signs stabilized and normal 
spontaneous respiration was confirmed. 
    After the patient was transferred to the ICU, arterial blood gas 
analysis (ABGA) and electrolyte studies were conducted and 
the results showed a pH of 7.334, PaCO2 of 44.8 mmHg, PaO2 of 
70.1 mmHg, base excess -2.7 mmol/L, HCO3
- 23.3 mmol/L, 
SaO2 of 93%, Na
+ 142 mmol/L, K
+ 4.2 mmol/L, Cl
- 103 mmol/L, 
Ca
2+ 1.16 mmol/L, and Mg
2+ 1.7 mg/dl; which were within their 
normal limits. However, chest X-ray revealed cardiomegaly 
and mild pulmonary edema, while ECG detected a T-wave 
inversion in leads II, III, aVF, and V2-6, and QTc prolongation 
to 547 ms (Fig. 1). On ultrasound, akinesia of the anteroseptum 
& inferoposterolateral wall of the left ventricle was detected, 
and in coronary angiography, the left ventricular ejection 
fraction was 38% demonstrating hyposystole, and an increase 
in the left ventricular cavity size to 60 mm were detected, 
while there were no other abnormalities seen. Thereafter, ECG 
was recorded daily on a continous basis with Holter monitor. 
Epinephrine provocation test was positive and hence the 
patient was diagnosed with LQTS. On the fifth day of admission, 
implantable cardioverter-defibrillator (ICD) was implanted. 
Afterwards, the patient’s vital signs improved and were within 
their normal ranges and the QTc intervals on ECG also showed 
normalization. Hence on the twelfth day of admission, open 
reduction of the fractured zygomatic bone on the right side was 
performed under general anesthesia. 
    In the preoperative evaluation, blood tests showed findings 
within their normal ranges. On ECG, T-wave inversion persisted 
in leads II, III, and aVF. Normal T-waves were seen in V2-6 
and the QTc of 406 ms was also within its normal limits (Fig. 
1). As a premedication, 2.5 mg of midazolam was injected 
intravenously at the entrance of the OR. On arrival in the OR, 
vital signs were measured: BP 110/75 mmHg; HR 85 beats/min; 
SpO2 95%. Before induction of anesthesia, preoxygenation was 
performed with 6 L/min of O2, and propofol administration was 
initiated with an effect-site concentration of 4.0 μg/ml using 
a target-controlled infusion device (Orchestra
TM, Fresenius 
Vial S.A, France). Afterwards, 0.15 μg/kg/min of remifentanil, 
a useful opioid, was continuously injected intravenously, loss 
of consciousness was confirmed. Following complete muscle 
relaxation by an intravenous injection of 70 mg of rocuronium, 
tracheal intubation was performed. BP recorded immediately 
after intubation was 100/60 mmHg, and HR was 75 beats/
min. After the patient’s vital signs stabilized, propofol was 
Fig. 1. Electrocardiography in the lead II rhythm strip, (A) before 
induction (55 BPM, QTc = 439 ms), (B) after induction at ICU (59 
BPM, QTC = 547 ms), (C) before reoperation (68 BPM, QTC = 406 ms).S116 www.ekja.org
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infused with an effect-site concentration of 2.5-3.0 μg/ml, and 
continuous remifentanil infusion was given at a rate of 0.05 μg/
kg/min to 0.10 μg/kg/min. During anesthesia, no particular 
changes were noted in BP and on ECG. The left radial artery 
was catheterized to monitor the arterial pressure. Similarly, 
HR, ECG, SpO2, end-tidal CO2, etc. were monitored, but they 
did not reveal any particular changes. After completion of the 
operation, muscle relaxation was reversed immediately with 
an infusion of glycopyrrolate 0.2 mg and pyridostigmine 10 
mg. After confirming normal spontaneous respiration and 
consciousness, the patient was extubated and when his vital 
signs were found to be stable, he was transferred to the recovery 
room (RR). The total time exposed to anesthesia was 3 hours 
and 45 minutes. In the RR, the patient was in a stable condition 
and after he fully recovered from the anesthesia, he was 
transferred to the general ward. On the nineth postoperative 
day, the patient was discharged without any complications.
Discussion
    LQTS is an inherited or acquired disorder, but is usually 
inherited, which may cause sudden death due to episodes 
of syncope, seizure, and ventricular tachycardia. It is a rare 
disorder, with an estimated prevalence of around 1 per 2,500-
10,000 [2]. In Korea, a study was performed by Koo et al. [3] on 
anesthetic management of a patient with congenital LQTS. It 
has been known that LQTS is caused by mutations in 1 of the 12 
genes and, these mutations may create abnormalities in cardiac 
ion channels [4], prolong ventricular repolarization, and prolong 
the QT interval, causing serious arrhythmias such as ventricular 
tachycardia or torsades de pointes. In general, a corrected 
QT (QTc) interval is considered prolonged if the interval is 
longer than 440 ms. The LQTS diagnostic criteria proposed by 
Schwartz et al. [5], are based on ECG findings, clinical history 
of syncope or congenital deafness, and family history. Difinite 
LQTS is difined by the LQTS score reaches 4 or more points 
(Table 1). However, it is difficult to diagnose LQTS accurately 
only on the basis of the clinical history and ECG findings 
because of variable penetrance and genetic heterogeneity. 
Therefore, genetic testing is recommended [6], but diagnostic 
genotyping is very expensive and hence it is not practically 
feasible. Furthermore, 30% of patients with congenital LQTS 
have apparently normal phenotype and thus a normal QT 
interval, so they remain undiagnosed until an initiating event 
[7]. In addition, a variety of commonly prescribed drugs given 
to patients can prolong cardiac repolarization, prolong the QTc. 
These patients are considered as potential or silent LQTS gene 
carriers and 70% of them have a normal QTc interval until they 
are exposed to a provoking drug [8].
    In the present case at the first attempt for open reduction, 
there were no preoperative abnormal findings in the patient’s 
clinical history and family history, and the QTc on preoperative 
ECG was 439 ms, which can bearly be considered as prolonged 
QTc. Also, Per the LQTS score was 0; hence it was difficult 
to term the patient as a LQTS case and was a low risk case. 
However, when the medication for anesthetic induction was 
administered and tracheal intubation was performed, ventri-
cular tachycardia and fibrillation did occur. After defibrillation, 
the patients vital signs stabilized. Later, based on the findings 
on ECG taken in the ICU which revealed that the QTc was 
prolonged to 547 ms and T-wave inversion was detected in 
leads II, III, aVF, and V2-6, the patient was diagnosed with 
LQTS. Therefore, it seems plausible to assume that he was an 
asymptomatic potential LQTS patient and the medication 
administered for anesthetic induction triggered LQTS.
    Even though from many studies, the effects of anesthetic 
drugs on QT interval have been known, it is difficult to 
identify which particular medication is responsible for the 
QT interval prolongation as several drugs are administered 
simultaneously. To date, there has been no study reporting the 
usage of only one single anesthetic drug to induce anesthesia 
and investigating its effect on the QTc interval. In this case for 
rapid-sequence induction, thiopental and succinylcholine were 
injected, while 2.0 vol% of sevoflurane was also administered 
shortly. According to Saarnivaara and Lindgren [9], thiopental 
Table 1. 1993 LQTS Diagnostic Criteria
Points
ECG findings*
    A. QTc
†
         ≥480 msec
1/2
         460-470 msec
1/2
         450 msec
1/2 (in males)
    B. Torsades de pointes
‡
    C. T wave alternance
    D. Notched T wave in three leads
    E. Low heart rate for age
§
Clinical history
    A. Syncope
‡
         With stress
         Without stress
    B. Congenital deafness
Family history 
||
    A. Family members with definite LQTS
¶
    B. Unexplained sudden cardiac death before
           age 30 in immediate family members
3
2
1
2
1
1
0.5
2
1
0.5
1
0.5
LQTS: long QT syndrome. *In the absence of medications or 
disorders known to affect these ECG features. 
†QTc calculated 
by Bazette's formula, where QTc = QT/       . 
‡Mutually exclusive. 
§Resting heart rate below the second percentile for age. 
||The same 
family member cannot be counted in A and B. 
¶Definite LQTS is 
defined by a LQTS score ≥4. Scoring: ≤1 point, low probability of 
LQTS; 2 to 3 points, intermediate probability of LQTS; ≥4 points, high 
probability of LQTS.
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prolongs the QTc in the healthy patients and succinylcholine 
is effective in maintaining the QTc interval prolongation. 
Yildirim et al. [10] have reported that sevoflurane, isoflurane, 
and desflurane all prolong the QTc and there is a possibility 
that all the medications administered for anesthetic induction 
prolong the QTc. As sudden sympathetic activation due to 
tracheal intubation may also be a cause of prolongation of the 
QTc; Galloway and Glass [11] have suggested that drugs which 
activate the sympathetic nervous system; such as ketamine and 
pancuronium, should be avoided. 
    Magnesium sulphate is the treatment of choice in LQTS 
patients when an arrhythmic episode such as torsades de 
pointes develops. If magnesium sulphate is ineffective in 
suppressing torsades de pointes, temporary transvenous 
pacing is a viable alternative and it is recommended to apply 
transvenous pacing to the right atrium through the central 
venous catheter. In the present case, we did not have time 
for these options due to the transition into VF, and hence, 
defibrillation had to be attempted promptly. The use of drugs 
such as epineprine and norepinephrine that activate the 
sympathetic nervous system may lead to further prolongation of 
QTc interval. In this case wherein the patient had VF and cardiac 
arrest without measurable BP, we however had to administer 
epinephrine while performing CPR by chest compression.
    The purpose of the treatment for LQTS is to prevent torsades 
de pointes and sudden cardiac death. Generally, beta-
receptor blocking agents (β-blockers) are the first choice in the 
treatment of LQTS. Recently in the cases of episodes of syncope, 
torsades de pointes, or cardiac arrest requiring CPR despite 
the administration of β-blockers, ICD implantation is being 
performed. ICD implantation is also recommended for patients 
with prolonged QTc to 550-600 ms or more; dangerous enough 
for leading to sudden cardiac death [12]. Even though ICD 
does not prevent torsades de pointes, it is known that ICD 
reduces the risk of torsades de pointes or sudden cardiac death 
due to VF [13]. In the present case, because the patient had a 
prolonged QTc of 547 ms and had a history of cardiac arrest 
accompanied with VF, ICD implantation was performed and 
HR was well maintained at 70-80 beats/min. 
    Patients with LQTS require a careful anesthetic management. 
Preoperatively, β-blockers should be administered; HR should 
maintained below 130 beats/min; normal serum electrolyte 
levels should be maintained. It is recommended to avoid 
any medical agents that have the potential to prolong the 
QT interval. It is also important to pay attention to sudden 
activation of the sympathetic nervous system, and ICD needs 
to be evaluated. In the preoperative assessment of the present 
case, the patient did not complain of any particular symptoms, 
and the blood test findings including the serum electrolyte 
levels were normal. In the present case at the second attempt 
for open reduction, in the preoperative ECG evaluation, 
inverted T-waves in lead V2-6 detected on ECG taken in the 
ICU were normalized; the QTc was in the normal range; HR 
was well maintained to 70-80 beats/min. Therefore, β-blockers 
were not used and the operation was started after ICD was 
evaluated. It has been reported that inhalation anesthetics such 
as sevoflurane, isoflurane, and desflurane may prolong the QTc 
[10] and Michaloudis et al. [14] have suggested that the propofol 
does not affect the QTc interval much, while midazolam 
does not influence the QTc interval either. In light of these 
suggestions, in order to allay the patient’s fear, we also gave 
intravenous administration of midazolam as a premedication 
to prevent sympathetic stimulation due to tracheal intubation 
and the operation and to minimize the influence on the QTc 
interval, we performed total intravenous anesthesia using 
mainly propofol and remifentanil, which was well maintained 
without any significant changes on vital signs and ECG. Recent 
research has identified that atropine and glycopyrrolate can 
prolong the QT interval [15]. Hence, it is safe to avoid the 
reversal of muscle relaxation as far as possible. In the present 
case, however, BP and HR were very well maintained and 
muscle relaxation reversal was performed, and it did not lead to 
any problems.
    In conclusion, our patient may be a potential LQTS gene 
carrier, and was diagnosed with LQTS after he was exposed to 
the provoking anesthesia-inducing drugs, which precipitated 
the malignant arrhythmia. A variety of commonly administered 
drugs for general anesthesia can affect the QT interval and 
cause unexpected life-threatening situations. It is beneficial to 
make a proper choice of anesthetic drugs which do not affect 
the QT interval for both; the patients diagnosed with LQTS 
and the patients not diagnosed with LQTS, as a patient not 
diagnosed with LQTS may also be a potential LQTS patient and 
exposure to a provoking drug can make such a patient transit to 
an LQTS phase. Needless to say, that more attention should be 
directed to the anesthetic management of patients diagnosed 
with LQTS.
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